{"id":3901,"date":"2009-05-12T11:52:44","date_gmt":"2009-05-12T16:52:44","guid":{"rendered":"http:\/\/www.sequence-inc.com\/fraudfiles\/?p=3901"},"modified":"2012-03-02T14:39:11","modified_gmt":"2012-03-02T20:39:11","slug":"usanas-sneaky-disclosure","status":"publish","type":"post","link":"https:\/\/www.sequenceinc.com\/fraudfiles\/usanas-sneaky-disclosure\/","title":{"rendered":"USANA&#8217;s Sneaky Disclosure"},"content":{"rendered":"<p>In the <a href=\"http:\/\/www.sec.gov\/Archives\/edgar\/data\/896264\/000110465909031765\/a09-11124_110q.htm\">Usanan Health Sciences (NASDAQ:USNA) most recent 10-Q<\/a> filed with the SEC, the company makes reference to restated financial statements:<!--more--><\/p>\n<blockquote><p>During 2008, the Internal Revenue Service (\u201cIRS\u201d) commenced an audit of the Company\u2019s tax returns. In January\u00a02009, the IRS communicated its intent to disallow deductions claimed by the Company under Section\u00a0162(m)\u00a0of the Internal Revenue Code (\u201cIRC\u201d). In February\u00a02009, the Company settled the Section\u00a0162(m)\u00a0matter with the IRS. Under the settlement, the cumulative tax impact to the Company is the loss of $11.8\u00a0million in tax deductions resulting in estimated taxes due of $4.4\u00a0million, plus $0.8\u00a0million in interest. The $4.4\u00a0million in taxes due resulted in an increase to current liabilities and corresponding reduction in stockholders\u2019 equity in the affected periods. The $0.8\u00a0million in interest resulted in an increase to current liabilities with a corresponding increase to income tax expense in the affected periods.<\/p><\/blockquote>\n<p>Doesn&#8217;t sound like a big deal, right? Well it&#8217;s probably not a big deal if you don&#8217;t care what Section 162(m) of the Internal Revenue Code is. And Usana certainly isn&#8217;t <strong>volunteering<\/strong> that information.<\/p>\n<p>That part of the code is related to excessive employee compensation, and the <a href=\"http:\/\/sec.gov\/Archives\/edgar\/data\/896264\/000115752309000383\/a5877193ex99.htm\">years under audit included 2003 through 2006<\/a>. Usana had $11.8 million of its deductions related to <strong>excessive employee compensation<\/strong> (that&#8217;s also called lining the pockets of the executives) disallowed for those years.<\/p>\n<p>Why does this even matter? It just provides further proof that the real winners in the multi-level marketing game are the owners and executives of the MLM companies themselves, not those who participate in the pyramid.<\/p>\n<p>For those with an interest in the accounting and auditing issues, note that Usana admits their controls were deficient 2006, but says they were corrected in 2006. Really? Then how is it that the tax issue came up AFTER 2006, if your controls in 2006 were sufficient?<\/p>\n<p>Here&#8217;s what Usana says<a href=\"http:\/\/sec.gov\/Archives\/edgar\/data\/896264\/000110465909013573\/filename1.htm\"> in their letter to the SEC<\/a>:<\/p>\n<blockquote><p>As part of its assessment, management concluded that the tax matters disclosed herein resulted from a control deficiency in the Company\u2019s internal controls regarding the tax compliance of equity awards granted prior to 2006 by the Compensation Committee. Although a control deficiency was identified, management concluded that this control deficiency was remediated by the Company during 2006 and did not constitute a material weakness in our internal controls over financial reporting as of January\u00a03, 2009.<\/p><\/blockquote>\n<p>If everything was &#8220;remediated&#8221; in 2006, why did it take an IRS audit to force the changes to the financial statements?<\/p>\n","protected":false},"excerpt":{"rendered":"<p>In the Usanan Health Sciences (NASDAQ:USNA) most recent 10-Q filed with the SEC, the company makes reference to restated financial statements:<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[827,184],"tags":[52,921],"class_list":["post-3901","post","type-post","status-publish","format-standard","hentry","category-public-companies","category-pyramid-schemes-mlm","tag-usana-health-sciences","tag-usna"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"","jetpack_shortlink":"https:\/\/wp.me\/p6Z0e-10V","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/posts\/3901","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/comments?post=3901"}],"version-history":[{"count":0,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/posts\/3901\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/media?parent=3901"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/categories?post=3901"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sequenceinc.com\/fraudfiles\/wp-json\/wp\/v2\/tags?post=3901"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}